Core Scientific, Inc./tx (CORZ)
↓ Download CSV- Sector Finance & Real Estate
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Core Scientific, Inc./tx reported revenue of $319.02M, down 37.5% from the prior year. The company ran a net loss, with a net margin of -90.5% and a gross margin of 11.9%. It held $2.35B in total assets against $3.31B in total liabilities.
Key ratios (FY2025)
11.9%
Gross margin
-77.0%
Operating margin
-90.5%
Net margin
-37.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $319.02M | $510.67M | $502.40M | $640.31M | $544.48M | $60.32M | — |
| Cost of Revenue | $281.12M | $389.60M | $378.94M | $631.91M | $305.62M | $50.93M | — |
| Gross Profit | $37.90M | $121.07M | $123.46M | $8.40M | $238.86M | $9.39M | — |
| Operating Income | -$245.59M | -$142.06M | $8.96M | -$2.11B | $131.49M | -$6.33M | — |
| Net Income | -$288.62M | -$1.44B | -$246.49M | -$2.15B | $47.31M | -$12.21M | — |
| EPS (Diluted) | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 | $-0.14 | — |
| Total Assets | $2.35B | $1.48B | $712.16M | $807.69M | $2.44B | $15.0K | — |
| Total Liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.05B | $400 | — |
| Shareholders' Equity | -$962.74M | -$943.05M | -$596.94M | -$409.35M | $1.34B | $89.22M | $106.33M |
| Cash & Equivalents | $311.38M | $836.20M | $50.41M | $15.88M | $117.87M | — | — |
| Operating Cash Flow | $278.25M | $42.90M | $65.11M | $205.19M | -$56.73M | -$23.77M | — |
| Capital Expenditures | $729.00M | $94.96M | $16.16M | $383.98M | $0 | $0 | — |
| Shares Outstanding | 318.07M | 255.83M | 379.86M | 340.65M | 233.31M | 157.60M | — |